Elevated levels of survivin and livin mRNA in bronchial aspirates as markers to support the diagnosis of lung cancer

International Journal of Cancer

Volumn 132, Issue 5, 2013, Pages 1098-1104

  Li, Jian ^a   Chen, Ping ^a   Li, Xiao Qin ^a   Bao, Qian Lei ^a   Dai, Chun Hua ^a   Ge, Li Ping ^a  

^a AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

Author keywords

diagnosis; livin; lung cancer; molecular marker; survivin

Indexed keywords

LIVIN; MESSENGER RNA; SURVIVIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BRONCHIAL ASPIRATION PROCEDURE; BRONCHOSCOPY; BRONCHUS BIOPSY; BRONCHUS CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC PERFORMANCE; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVIN GENE; LUNG CANCER; LUNG DISEASE; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SURVIVIN GENE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BRONCHI; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; FEMALE; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 84872846456     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27757     Document Type: Article

References (29)

1. Roth K, Hardie JA, Andreassen AH, et al. Predictors of diagnostic yield in bronchoscopy: a retrospective cohort study comparing different combinations of sampling techniques. MBC Pulm Med 2007; 8: 2.
2. Baaklini WA, Reinoso MA, Gorin AB, et al. Diagnostic yield of fiberoptic bronchoscopy in evaluating solitary pulmonary nodules. Chest 2000; 117: 1049-54.
3. Lee HS, Kwon SY, Kim KD, et al. Determinants of diagnostic bronchial washing in peripheral lung cancer. Int J Tuberc Lung Dis 2007; 11: 227-32.
4. Hirsch FR, Merrick DT, Franklin WA,. Role of biomarker for early detection of lung cancer and chemoprevention. Eur Respir J 2009; 19: 1151-8.
5. Alfieri DC,. Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 2003; 22: 8581-9.
6. Li F, Ambrosini G, Chu EY, et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 1998; 396: 580-4.
7. Altieri DC,. Validating survivin as a cancer therapeutic target. Net Rev Cancer 2003; 3: 46-54.
8. Ambrosini G, Adida C, Alfieri DC,. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997; 3: 917-21.
9. Velculescu VE, Madden SL, Zhang L, et al. Analysis of human transcriptomes. Nat Genet 1999; 23: 387-8.
10. Altieri DC,. The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol Med 2001; 7: 542-7.
11. Moussa O, Abol-Enein H, Bissada NK, et al. Evaluation of survivin reverse transcriptase-polymerase chain reaction for noninvasive detection of bladder cancer. J Urol 2006; 175: 2312-6.
12. Kenney DM, Geschwindt RD, Kary MR, et al. Detection of newly diagnosed bladder cancer, bladder recurrence and bladder cancer in patients with hematuria using quantitative rt-PCR of urinary survivin. Tumor Biol 2007; 28: 57-62.
13. Wang T, Qin X, Wang Z, et al. Detection of cell BIRC5 mRNA in effusion and its potential diagnostic value for differentiating malignant and benign effusion. Int J Cancer 2009; 125: 1921-5.
14. Lan C-C, Wu Y-K, Lee C-H, et al. Increased survivin mRNA in malignant pleural effusion in significantly correlated with survival. Jpn J Clin Oncol 2010; 40: 234-40.
15. Wu YK, Chen KT, Kuo YB, et al. Quantitative detection of survivin in malignant pleural effusion for the diagnosis and prognosis of lung cancer. Cancer Lett 2009; 273: 331-5.
16. Yie SM, Lou B, Ye SR, et al. Clinical significance of detecting survivin-expressing circulating cancer cells in patients with non-small cell lung cancer. Lung Cancer 2009; 63: 284-90.
17. Shen CX, Hu LH, Xia L, et al. Quantitative real-time RT-PCR detection for survivin, CK20 and CEA in peripheral blood of colorectal cancer patients. Jpn J Clin Oncol 2008; 38: 770-6.
18. Lin JH, Deng G, Huang Q, et al. KIAP, a novel member of the inhibitor of apoptosis protein family. Biochem Biophys Res Commun 2002; 279: 820-31.
19. Kasof GM, Gomes BC,. Livin, a novel inhibitor of apoptosis protein family member. J Bio Chem 2001; 276: 3238-46.
20. Vucic D, Stennicke HR, Pisabarro MT, et al. ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas. Curr Biol 2000; 10: 1359-66.
21. Tanabe H, Yagihashi A, Tsuji N, et al. Expression of survivin mRAN and livin mRNA in non-small cell lung cancer. Lung Cancer 2004; 46: 299-304.
22. Gazzaniga P, Gradilone A, Giulian, L, et al. Expression and prognostic significance of livin, survivin and other apoptosis-related genes in the progression of superficial bladder cancer. Ann Oncol 2003; 14: 85-90.
23. Xiang Y, Yao H, Wang S, et al. Prognostic value of survivin and livin in nasopharyngeal carcinoma. Laryngoscope 2006; 116: 126-130.
24. Haferkamp A, Bedke J, Vetter C, et al. High nuclear livin expression is a favourable prognostic indicator in renal cell carcinoma. Br J Urol Int 2008; 102: 1700-6.
25. Hariu H, Hirohashi Y, Torigoe T, et al. Aberrant expression and potency as a cancer immunotherapy target of inhibitor of apoptosis protein family, livin/ML-IAP in lung cancer. Clin Cancer Res 2005; 11: 1000-9.
26. Dai C-H, Li J, Shi S-B, et al. Survivin and Smac gene expressions but not livin are predictors of prognosis in non-small cell lung cancer patients treated with adjuvant chemotherapy following surgery. Jpn J Clin Oncol 2010; 40: 327-35.
27. Greenberg AK, Lee MS,. Biomarker for lung cancer: clinical uses. Curr Opin Pulm Med 2007; 13: 249-55.
28. Chorostowska-Wynimko J, Szpechcinski A,. The impact of genetic markers on the diagnosis of lung cancer: a current perspective. J Thorac Oncol 2007; 2: 1044-51.
29. Yagihashi A, Asanuma K, Tsuji N, et al. Detection of anti-livin antibody in gastrointestinal cancer patients. Clin Chem 2003; 49: 1206-8.